Serological Tumor Viability Risk Index Comprising Alpha-Fetoprotein and C-reactive Protein Identifies Eligible Liver Transplant Patients with Hepatocellular Carcinoma beyond Milan and Up-to-Seven Criteria

2018 ◽  
Vol 102 ◽  
pp. S251
Author(s):  
Arno Kornberg ◽  
Ulrike Witt ◽  
Martina Schernhammer ◽  
Jennifer Kornberg ◽  
Helmut Friess ◽  
...  
2002 ◽  
Vol 6 (2) ◽  
pp. 153-160 ◽  
Author(s):  
Maria Their ◽  
Kai Rönnholm ◽  
Heikki Sairanen ◽  
Christer Holmberg ◽  
Hannu Jalanko

Oncology ◽  
2018 ◽  
Vol 96 (1) ◽  
pp. 25-32 ◽  
Author(s):  
Aslı Suner ◽  
Brian I. Carr ◽  
Hikmet Akkiz ◽  
Gökhan Karakülah ◽  
Oguz Üsküdar ◽  
...  

Author(s):  
Kotaro Matsumoto ◽  
Kentaro Kikuchi ◽  
Ayako Hara ◽  
Hiromichi Tsunashima ◽  
Koichi Tsuneyama ◽  
...  

AbstractA 25-year-old woman with fever and epigastric pain was referred to our hospital. Blood examination showed significant liver dysfunction, markedly high C-reactive protein (CRP 19.1 mg/dL) and procalcitonin (48.3 ng/mL) levels. Dynamic computed tomography showed a tumor approximately 120 mm in size in the right lobe of the liver, but with no abscess formation. The patient was hospitalized and started on antibiotics; her CRP level improved, but the procalcitonin level did not decrease. Histopathological examination of the liver tumor biopsy revealed fibrolamellar hepatocellular carcinoma (FLC). Positive staining of the FLC with an anti-procalcitonin antibody suggested the production of procalcitonin.


2020 ◽  
Vol 44 (5) ◽  
pp. 275-282
Author(s):  
G. Seller-Pérez ◽  
J.E. Barrueco-Francioni ◽  
R. Lozano-Sáez ◽  
M.M. Arrebola-Ramírez ◽  
M.J. Diez-de-los-Ríos ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document